TAK

+4.2%🔴 Potential overreaction

Takeda Pharmaceutical Company Limited · Healthcare

$19.81Vol 1.50M · 1.9× normalMkt cap +$2.56Blive · 2026-10-15 ET

What happened

Move

+4.2%

Price

$19.81

Volume

1.50M

1.9× normal

Market cap

$63.28B

+$2.56B today

Why it moved

Legal / regulatorylow confidence

Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 2026 — finnhub-news

Weak signal: legal / regulatory, 2.2pp above its sector, on 1.9× normal volume.

Verdict — was the move justified?

🔴 Potential overreaction

A 3.3σ move well beyond the sector with no identified fundamental or news driver — the reaction appears larger than currently visible evidence justifies. Likely flow/positioning-driven.

How unusual is this move

σ score

3.3σ

vs own 20d volatility

Percentile

99th

of 1276 daily moves

Avg daily move

±0.9%

own 5y average

vs sector

+2.2%

beyond sector median

Today’s move is among the largest 1% of TAK’s daily moves over the last 5 years — while the sector moved +2.0% and the market +1.2%.

What happened after similar moves

19 similar up moves in TAK’s 5-year history:

After 5 days

-0.1%

47% higher

After 20 days

+4.5%

74% higher

Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.

Fundamental context

Insider activity (90d): net selling $9.90M

Full fundamental analysis on PreMarketPrice

Pillar scores, financial statements, valuation history, news & more for TAK

→